Maximus
MMS NYSE Data Processing & Outsourced Services Financials FY2016βFY2025
Maximus' revenue rose 2.4% to $5.4 billion in fiscal 2025. Its operating margin was 9.7%, up from 9.2% a year earlier. Free cash flow was $366 million, down 8.7%. It paid out $516 million in dividends and buybacks, 141% of free cash flow. The diluted share count fell 5.8%.
What Maximus does
No business description yet.
- Legal name
- Maximus, Inc.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001032220-25-000053
0001032220
Revenue and margins
Maximus had $5.4B of revenue in fiscal 2025, up 2.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $366M in fiscal 2025, 6.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Maximus returned $516M to shareholders in fiscal 2025, 141% of free cash flow. The diluted share count fell 5.8%.
Value Maximus yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.1B and divides by 57.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 9.3x Β· peers 19.1x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Maximus can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $135M | $40.7M | $65.4M | $183M | $222M |
| Debt incl. finance leases | $1.5B | $1.4B | $1.3B | $1.1B | $1.3B |
| Net debt / EBITDA | 3.0x | 3.6x | 3.4x | 1.8x | 2.0x |
| Debt / equity | 1.0x | 0.9x | 0.8x | 0.6x | 0.8x |
| Interest coverage | 27.7x | 7.1x | 3.5x | 5.9x | 6.3x |
| Current ratio | 1.4x | 1.3x | 1.5x | 1.5x | 1.6x |
| Quick ratio | 1.4x | 1.3x | 1.5x | 1.5x | 1.6x |
| Total assets | $4.1B | $4.0B | $4.0B | $4.1B | $4.1B |
| Total liabilities | $2.6B | $2.4B | $2.3B | $2.3B | $2.4B |
| Shareholders' equity | $1.5B | $1.5B | $1.7B | $1.8B | $1.7B |
| Net debt (β = net cash) | $1.4B | $1.3B | $1.2B | $949M | $1.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.3M
4 insiders
Sold, 12 months
$0.4M
2 insiders
Of sales under plans
100%
$0.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Jan MadsenDirector | Sold plan | 742 | $72.25 | $0.1M | Form 4 |
| Feb 10, 2026 | Bruce CaswellCEO & President, Director | Bought | 3,175 | $78.45 | $0.2M | Form 4 |
| Feb 9, 2026 | David MutrynChief Financial Officer | Bought | 1,000 | $75.63 | $0.1M | Form 4 |
| Dec 3, 2025 | Michelle F. LinkChief of Human Resources | Sold plan | 4,039 | $86.84 | $0.4M | Form 4 |
| Nov 28, 2025 | Gayathri RajanDirector | Bought | 42 | $86.11 | $0.0M | Form 4 |
| Nov 28, 2025 | Michael J. WarrenDirector | Bought | 14 | $86.11 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 8 / 9 | 7 / 9 |
| Accruals ratio | β3.8% | β5.1% | β2.7% |
| Altman Z'' | 2.71 | 3.27 | 3.24 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Maximus MMS | $3.3B | 2.4% | 9.7% | 6.7% | 13.6% | 9.3x | 7 | |
| Genpact G | $7.0B | 6.6% | 14.8% | 14.5% | 19.4% | 12.1x | 7 | Compare β |
| Broadridge Financial Solutions BR | $21.5B | 8.5% | 17.4% | 17.1% | 18.3% | 19.1x | 9 | Compare β |
| EXL EXLS | $6.6B | 13.6% | 15.0% | 14.3% | 28.4% | 27.1x | 8 | Compare β |
| Terex TEX | $5.9B | 5.7% | 8.8% | 5.9% | 9.0% | β | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.4B | $2.5B | $2.4B | $2.9B | $3.5B | $4.3B | $4.6B | $4.9B | $5.3B | $5.4B |
| Gross profit | $562M | $612M | $594M | $671M | $711M | $947M | $940M | $1.0B | $1.3B | $1.3B |
| Operating income | $287M | $314M | $296M | $317M | $288M | $409M | $326M | $295M | $489M | $528M |
| Interest expense | $4.1M | $2.2M | $1.0M | $3.0M | $2.1M | $14.7M | $46.0M | $84.1M | $82.4M | $84.1M |
| Pretax income | $286M | $314M | $299M | $317M | $287M | $384M | $277M | $210M | $407M | $445M |
| Income tax | $106M | $102M | $78.4M | $76.8M | $72.6M | $92.5M | $73.3M | $48.5M | $99.6M | $126M |
| Net income | $178M | $209M | $221M | $241M | $215M | $291M | $204M | $162M | $307M | $319M |
| Diluted EPS | $2.69 | $3.17 | $3.35 | $3.72 | $3.39 | $4.67 | $3.29 | $2.63 | $4.99 | $5.51 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $180M | $336M | $317M | $357M | $245M | $517M | $290M | $314M | $515M | $429M |
| Capital expenditure | β | β | $26.5M | $66.8M | $40.7M | $36.6M | $56.1M | $90.7M | $114M | $63.2M |
| Free cash flow | β | β | $290M | $290M | $204M | $481M | $234M | $224M | $401M | $366M |
| Depreciation and amortization | $58.4M | $55.8M | $51.9M | $52.4M | $64.5M | $46.4M | $42.3M | $54.7M | $34.0M | $41.7M |
| Stock-based compensation | $18.8M | $21.4M | $20.2M | $20.8M | $23.7M | $28.6M | $30.5M | $29.5M | $35.3M | $41.2M |
| Acquisitions | $46.7M | $2.7M | $0.0M | $437M | $7.1M | $1.8B | $14.3M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $33.3M | $28.9M | $66.9M | $47.4M | $167M | $3.4M | $96.1M | $0.0M | $73.1M | $448M |
| Dividends paid | $11.7M | $11.7M | $11.7M | $63.9M | $70.2M | $68.8M | $68.7M | $68.1M | $72.9M | $68.7M |
| Dividends and buybacks | $45.0M | $40.5M | $78.6M | $111M | $237M | $72.2M | $165M | $68.1M | $146M | $516M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $66.2M | $166M | $370M | $106M | $71.7M | $135M | $40.7M | $65.4M | $183M | $222M |
| Total debt | $166M | $0.7M | β | $9.9M | $28.9M | $1.5B | $1.4B | $1.3B | $1.1B | $1.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $621M | $657M | $809M | $789M | $933M | $1.1B | $1.0B | $1.1B | $1.2B | $1.3B |
| Current liabilities | $341M | $316M | $277M | $364M | $561M | $789M | $774M | $723M | $808M | $765M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $132M | $102M | $77.5M | $99.6M | $66.7M | $62.6M | $52.3M | $38.8M | $39.0M | $31.0M |
| Total assets | $1.3B | $1.4B | $1.5B | $1.7B | $2.0B | $4.1B | $4.0B | $4.0B | $4.1B | $4.1B |
| Total liabilities | $596M | $405M | $376M | $498M | $783M | $2.6B | $2.4B | $2.3B | $2.3B | $2.4B |
| Shareholders' equity | $749M | $940M | $1.1B | $1.2B | $1.2B | $1.5B | $1.5B | $1.7B | $1.8B | $1.7B |
| Margins | ||||||||||
| Gross margin | 23.4% | 25.0% | 24.9% | 23.3% | 20.5% | 22.3% | 20.3% | 21.0% | 23.6% | 24.6% |
| Operating margin | 11.9% | 12.8% | 12.4% | 11.0% | 8.3% | 9.6% | 7.0% | 6.0% | 9.2% | 9.7% |
| EBITDA margin | 14.4% | 15.1% | 14.5% | 12.8% | 10.2% | 10.7% | 8.0% | 7.1% | 9.9% | 10.5% |
| Net margin | 7.4% | 8.5% | 9.2% | 8.3% | 6.2% | 6.8% | 4.4% | 3.3% | 5.8% | 5.9% |
| FCF margin | β | β | 12.1% | 10.0% | 5.9% | 11.3% | 5.1% | 4.6% | 7.6% | 6.7% |
| Returns | ||||||||||
| Return on capital | 22.5% | 25.9% | β | β | 18.3% | 15.3% | 8.4% | 7.9% | 13.1% | 13.6% |
| Return on capital employed | 29.8% | 30.7% | 26.6% | 24.7% | 20.3% | 17.1% | 10.0% | 9.1% | 14.8% | 15.9% |
| Return on equity | 26.2% | 24.8% | 21.8% | 20.7% | 17.2% | 21.4% | 13.5% | 10.1% | 17.5% | 18.1% |
| Return on assets | 13.6% | 15.5% | 15.7% | 15.0% | 11.4% | 9.5% | 5.0% | 4.1% | 7.6% | 7.8% |
| Growth | ||||||||||
| Revenue growth | 14.5% | 2.0% | β2.4% | 20.7% | 19.9% | 22.9% | 8.9% | 5.9% | 8.2% | 2.4% |
| Net income growth | 13.1% | 17.4% | 5.4% | 9.1% | β10.9% | 35.8% | β30.0% | β20.6% | 89.7% | 4.0% |
| EPS growth | 14.5% | 17.8% | 5.7% | 11.0% | β8.9% | 37.8% | β29.6% | β20.1% | 89.7% | 10.4% |
| FCF growth | β | β | β | β0.1% | β29.7% | 135.8% | β51.4% | β4.3% | 79.3% | β8.7% |
| Share count change | β1.6% | β0.3% | β0.2% | β1.7% | β2.3% | β1.5% | β0.6% | β0.8% | 0.1% | β5.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.3x | β0.5x | β | β0.3x | β0.1x | 3.0x | 3.6x | 3.4x | 1.8x | 2.0x |
| Debt / equity | 0.2x | 0.0x | β | 0.0x | 0.0x | 1.0x | 0.9x | 0.8x | 0.6x | 0.8x |
| Interest coverage | 69.3x | 145.0x | 295.5x | 107.2x | 140.0x | 27.7x | 7.1x | 3.5x | 5.9x | 6.3x |
| Current ratio | 1.8x | 2.1x | 2.9x | 2.2x | 1.7x | 1.4x | 1.3x | 1.5x | 1.5x | 1.6x |
| Quick ratio | 1.8x | 2.1x | 2.9x | 2.2x | 1.7x | 1.4x | 1.3x | 1.5x | 1.5x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | β | β | 1.1% | 2.3% | 1.2% | 0.9% | 1.2% | 1.9% | 2.2% | 1.2% |
| Stock comp / revenue | 0.8% | 0.9% | 0.9% | 0.7% | 0.7% | 0.7% | 0.7% | 0.6% | 0.7% | 0.8% |
| Payouts / FCF | β | β | 27.1% | 38.4% | 116.3% | 15.0% | 70.5% | 30.4% | 36.4% | 141.0% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 8.0 | β | β | 5.0 | 7.0 | 5.0 | 8.0 | 8.0 | 7.0 |
| Altman Z'' | 4.9 | 6.9 | 8.2 | 6.9 | 5.1 | 2.5 | 2.5 | 2.7 | 3.3 | 3.2 |
| Accruals ratio | β0.1% | β9.4% | β6.8% | β7.2% | β1.6% | β7.4% | β2.1% | β3.8% | β5.1% | β2.7% |
Source: SEC EDGAR XBRL filings (CIK 0001032220). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.